These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29066358)

  • 21. Illuminating Parkinson's therapy with optogenetics.
    Chen Y; Xiong M; Zhang SC
    Nat Biotechnol; 2015 Feb; 33(2):149-50. PubMed ID: 25658280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.
    Kim JH; Auerbach JM; Rodríguez-Gómez JA; Velasco I; Gavin D; Lumelsky N; Lee SH; Nguyen J; Sánchez-Pernaute R; Bankiewicz K; McKay R
    Nature; 2002 Jul; 418(6893):50-6. PubMed ID: 12077607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.
    Wakeman DR; Hiller BM; Marmion DJ; McMahon CW; Corbett GT; Mangan KP; Ma J; Little LE; Xie Z; Perez-Rosello T; Guzman JN; Surmeier DJ; Kordower JH
    Stem Cell Reports; 2017 Jul; 9(1):149-161. PubMed ID: 28579395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies.
    Henchcliffe C; Parmar M
    J Parkinsons Dis; 2018; 8(s1):S131-S137. PubMed ID: 30584166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease.
    Barker RA;
    Nat Med; 2019 Jul; 25(7):1045-1053. PubMed ID: 31263283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell Therapies for Parkinson's Disease.
    Irion S
    Clin Transl Sci; 2019 Mar; 12(2):95-97. PubMed ID: 30771274
    [No Abstract]   [Full Text] [Related]  

  • 27. Challenges in the clinical advancement of cell therapies for Parkinson's disease.
    Skidmore S; Barker RA
    Nat Biomed Eng; 2023 Apr; 7(4):370-386. PubMed ID: 36635420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanisms and treatments of Parkinson disease].
    Pollak P
    Rev Prat; 1997 May; 47(10):1068-76. PubMed ID: 9208669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell therapy for Parkinson's disease: Why it doesn't work every time.
    Collier TJ; Sortwell CE; Mercado NM; Steece-Collier K
    Mov Disord; 2019 Aug; 34(8):1120-1127. PubMed ID: 31234239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic neurons for Parkinson's therapy.
    Lindvall O
    Nat Biotechnol; 2012 Jan; 30(1):56-8. PubMed ID: 22231097
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain repair and reprogramming: the route to clinical translation.
    Grealish S; Drouin-Ouellet J; Parmar M
    J Intern Med; 2016 Sep; 280(3):265-75. PubMed ID: 27539906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin-credible: skin cells used to generate neurons damaged by Parkinson’s disease.
    Regen Med; 2012 Sep; 7(5):631-2. PubMed ID: 22954432
    [No Abstract]   [Full Text] [Related]  

  • 33. From Skin to Brain: A Parkinson's Disease Patient Transplanted with His Own Cells.
    Parmar M; Björklund A
    Cell Stem Cell; 2020 Jul; 27(1):8-10. PubMed ID: 32619520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering a dopaminergic phenotype in stem/precursor cells: role of Nurr1, glia-derived signals, and Wnts.
    Arenas E
    Ann N Y Acad Sci; 2005 May; 1049():51-66. PubMed ID: 15965107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell-based therapy for Parkinson's disease.
    Correia AS; Anisimov SV; Li JY; Brundin P
    Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem cells and Parkinson's disease: toward a treatment, not a cure.
    Svendsen C
    Cell Stem Cell; 2008 May; 2(5):412-3. PubMed ID: 18462691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease?
    Lipski J; Nistico R; Berretta N; Guatteo E; Bernardi G; Mercuri NB
    Prog Neurobiol; 2011 Sep; 94(4):389-407. PubMed ID: 21723913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal grafts for Parkinson's disease: Decades in the making.
    Kordower JH; Olanow CW
    Proc Natl Acad Sci U S A; 2016 Jun; 113(23):6332-4. PubMed ID: 27247420
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.
    Kefalopoulou Z; Politis M; Piccini P; Mencacci N; Bhatia K; Jahanshahi M; Widner H; Rehncrona S; Brundin P; Björklund A; Lindvall O; Limousin P; Quinn N; Foltynie T
    JAMA Neurol; 2014 Jan; 71(1):83-7. PubMed ID: 24217017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.